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Genotyping circulating rotaviruses before and after 
introduction of rotavirus vaccine is useful for evaluating 
vaccine-associated changes in genotype distribution. We 
determined frequency of rotavirus genotypes among 61 
rotavirus-positive children hospitalized in Israel during the 
2005–06 rotavirus season. Accurate molecular epidemio-
logic data were recovered from afﬁ  nity-concentrated rota-
virus immobilized in rotavirus-positive bands from air-dried, 
diagnostic rotavirus rapid test strips (dipstick) stored at room 
temperature from 1 week to 5 years. G genotypes were 
identical for 21 paired dipsticks and suspensions, whereas 
dipsticks or suspensions detected an additional G genotype 
in 2 samples. RNA sequences from 7 pairs were identical. 
Phylogenetic analysis suggested previously unreported G2 
sublineages and G9 lineages. The ease with which dipsticks 
can be stored at local facilities and transported to central 
reference laboratories can reverse increasing difﬁ  culties in 
obtaining geographically representative stool samples and 
expand surveillance to regions lacking adequate laboratory 
facilities.
R
otavirus infection is a leading cause of gastroenteritis 
in children <5 years of age worldwide; children with 
severe dehydration and electrolyte imbalance require hos-
pitalization (1). In 2007 and 2008, the annual economic 
cost for hospitalization of rotavirus case-patients in Israel 
was US $4,578,489 in direct costs to the health system plus 
an additional household cost of $3,101,955 (2). Poor hy-
gienic conditions and lack of appropriate medical facilities 
in developing countries result in high infant mortality rates 
(1,3–5). 
The genes encoding the outer capsid viral proteins 
VP7 and VP4 form the basis of classiﬁ  cation of group A 
rotaviruses into G and P genotypes, respectively (6,7). Two 
live oral vaccines, monovalent Rotarix vaccine (GlaxoS-
mithKline, Research Triangle Park, NC, USA) and pen-
tavalent Rotatek vaccine (Merck, Rahway, NJ, USA) ef-
fectively reduced hospitalizations for subsequent infections 
with G1P[8], G2P[4], G3P[8], and G4P[8] rotaviruses by 
>85% (8,9). Rotavirus vaccines that are scheduled for in-
clusion in Israel’s national vaccination program after 2010 
may selectively change relative distributions of naturally 
cocirculating rotaviruses of different G and P genotypes. 
According to analysis of voluntary immunizations before 
universal vaccination, the effectiveness of rotavirus vac-
cine in preventing rotavirus gastroenteritis–associated hos-
pitalizations in Israel is already evident (10).
Simple to use, inexpensive, diagnostic rotavirus rapid 
test strips (dipsticks) identify group A rotavirus–positive 
stools in <30 minutes by lateral ﬂ  ow immunochromatogra-
phy without indicating the genotype. Dipsticks are dipped 
into saline stool suspensions. If rotavirus is present, a col-
ored band appears when indicator-linked rotavirus antibod-
ies bind to the virus, and this complex is trapped on a band 
of membrane-bound rotavirus antibody on the dipstick. 
With their growing use at point-of-care facilities and in lo-
cal hospital laboratories, fewer samples are available for 
genotyping by centralized reference laboratories. Obtaining 
geographically representative stool samples and expanding 
surveillance to regions lacking adequate laboratory facili-
ties is becoming increasingly difﬁ  cult. The ease with which 
dipsticks can be stored at local facilities and transported 
to central reference laboratories can help overcome these 
difﬁ  culties. We hypothesized that rotavirus trapped on ro-
tavirus-speciﬁ  c antibody bands, equivalent to afﬁ  nity con-
centrated rotavirus, might yield genotyping-quality RNA 
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from dipsticks that are easily archived locally and trans-
portable to centralized laboratories. In this study, our main 
objective was to determine the feasibility of recovering 
molecular epidemiologic data from rotavirus immobilized 
on air-dried diagnostic rotavirus dipsticks to compensate 
for the decreasing number of fecal samples reaching central 
reference laboratories.
Methods
Stool samples from 311 children hospitalized with acute 
gastroenteritis at Sheba Medical Center, Tel Hashomer, Is-
rael, during May 15, 2005–May 15, 2006, were suspended 
in saline. Rotavirus dipsticks (Hy Laboratories LTD, Re-
hovot, Israel) were used to identify rotavirus-positive stool 
samples. (For comparison with rotavirus ELISA with Dako 
reagents [Dako Diagnostics LTD, Glostrup, Denmark], 
diagnostic dipsticks from Hy-Laboratories and Novamed 
[Novamed, Jerusalem, Israel] had sensitivities of 98.5% ± 
3% and 92.3%, and speciﬁ  cities of 92.5% ± 1% and 93.5%, 
respectively [L.M. Shulman et al., unpub data].) The sec-
tion of the dipstick containing the rotavirus-speciﬁ  c bands 
from 14 rotavirus-positive dipsticks that had been stored 
at room temperature for at least 1 week were excised and 
placed into 120 μL saline. 
Rotaviral RNA was extracted from these rotavirus-
speciﬁ  c bands and from the corresponding saline stool sus-
pensions by using QIAmp Viral RNA Mini kits (QIAGEN, 
Valencia, CA, USA). RNA ampliﬁ  ed from rotavirus-spe-
ciﬁ  c bands from dipsticks archived at room temperature 5 
years earlier was similarly extracted. RNA was ampliﬁ  ed 
by using generic primers for reverse transcription–PCR 
(RT-PCR) (QIAGEN OneStep RT-PCR kits, QIAGEN) 
followed by heminested PCR (AmpliTaq Gold, Applied 
Biosystems, Foster City, CA, USA) with genotype-speciﬁ  c 
primers to identify G and P genotypes as described by Gou-
vea et al. (11) and Gunasena et al. (12), respectively. RT-
PCR products were gel puriﬁ  ed (QIAQuick Gel Extraction 
Kit, QIAGEN) or puriﬁ  ed directly (HiPure PCR Product 
Puriﬁ   cation Kit; Roche Applied Science, Indianapolis, 
IN, USA) from the PCR mix and sequenced by using an 
ABI PRISM Dye Deoxy Terminator cycle sequencing kit 
(Applied Biosystems) and the genotype-speciﬁ  c  primer 
and common primer from the heminested PCR reaction 
described. Reaction mixtures were analyzed on Applied 
Biosystems model 373 DNA automatic sequencing system 
to conﬁ  rm the RT-PCR genotyping results and for phylo-
genetic analysis. 
Sequences of the same genotype were truncated to the 
longest common length by using the Sequencher program 
(Genecodes, Ann Arbor, Michigan, USA). Nearest-neighbor 
phylogenetic trees were constructed from these sequences 
after the data were bootstrapped 1,000 times with ClustalX 
(13). The tree was analyzed by using NJplot (14). Sequences 
have been deposited in European Molecular Biology Labo-
ratory/GenBank/DNA Data Bank of Japan under accession 
nos. FN298858–FN298875, FN582119–FN582124, and 
HQ174462–HQ174463. Isolate names are linked to their 
speciﬁ  c accession numbers in the online Appendix Table 
(www.cdc.gov/EID/content/17/1/44-appT.htm).
This study was approved by the institutional review 
board of Chaim Sheba Medical Center (SMC-7606-09). 
Experiments were not performed on humans. All personal 
identiﬁ  cation was removed from the remnants of fecal sam-
ples sent to the National Center for Viral Gastroenteritis for 
rotavirus analysis. The viral RNA used for this study was 
obtained from these anonymous samples.
Results
To assess the suitability of RNA extracted from dip-
sticks for determining the VP7 genotype, we ﬁ  rst deter-
mined the VP7 G genotype of rotavirus in rotavirus-positive 
clinical samples from children hospitalized during May 15, 
2005–May 15, 2006. Of 311 stool samples, 61 were deter-
mined to be rotavirus positive by using diagnostic rotavirus 
dipsticks. The G genotype and P genotype of RNA in 54 of 
the 61 samples was determined by the size of the heminest-
ed PCR ampliﬁ  cation product as described. Mixed infec-
tions, e.g., >1 G (6 samples) and P genotypes (2 samples) 
in the same fecal suspension, were found in 8 (15%) of the 
54 positive samples. Taking into account mixed infections, 
we found G1, G2, G3, and G9 G genotypes in 79%, 5%, 
2%, and 15%, respectively, of the 62 rotaviruses identiﬁ  ed 
in the 54 clinical samples. The frequencies of associated G 
and P genotypes for isolates from the 2005–2006 rotavi-
rus season were 3% G1P[4], 76% G1P[8], 5% G2P[4], 2% 
G3P[8], 3% G9P[4], and 11% G9P[8].
We chose 18 rotavirus-positive clinical samples with 
which to study the feasibility of recovering molecular in-
formation from dipsticks. Thirteen were from children in-
fected with 1 G genotype of rotavirus and 5 from children 
simultaneously infected with rotaviruses belonging to 2 dif-
ferent G genotypes. Of the 13 infections by a single G geno-
type, 8 were G1, 3 were G2, and 1 each were G3 and G9. 
All 5 mixed infections, RoV-24_ISR05, RoV_41_ISR05, 
RoV_56_ISR06, RoV_57_ISR06, and RoV_60_ISR06, 
were simultaneous infections with G1 and G9 genotypes. 
Mixed infections were identiﬁ  ed by speciﬁ  c product size on 
gels and conﬁ  rmed by partial sequencing of the G1 product 
for all 4 patients whose G9 sequences appear in the Figure.
RNA was extracted from rotavirus-positive bands of 
dipsticks from the 18 clinical samples. The dipsticks had 
been stored for >1 week at room temperature. The qual-
ity of the RNA from all 18 extractions was sufﬁ  cient to 
enable determination of VP7 G genotypes by heminested 
RT-PCR. The genotypes obtained from the RNA extracted 
from dipsticks were identical to those from RNA extracted 
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from corresponding saline suspensions for 14 of the 18 
rotavirus-positive stool samples, including 3 samples from 
children with dual infections. In 2 mixed G1–G9 infec-
tions, G9, but not G1 RNA, was recovered, and G1 RNA 
was recovered from dipstick RNA in addition to G9 from 
a G9-infected child. A fourth dipstick from a G3 sample 
yielded a G3 and an equivocal G1 that did not appear in 
subsequent replicate heminested ampliﬁ  cations. In other 
words, 21 (92%) of 23 genotypes identiﬁ  ed from RNA ex-
tracted from 18 fecal suspensions were also identiﬁ  ed from 
RNA extracted from dipsticks, including 8 of 10 genotypes 
from 5 samples simultaneously infected with rotaviruses of 
2 different genotypes.
Rotaviral VP7 RNA suitable for genotyping was also 
recovered from all 5 air-dried rotavirus-positive dipsticks 
that had been stored at room temperature for 5 years. The 
G genotypes of the rotavirus in the fecal suspensions from 
the 5 archived dipsticks from 2002 were unknown, and 
the suspensions were no longer available for comparison. 
One of the dipsticks was manufactured by Hy Laborato-
ries; the remaining 4 were manufactured by Novamed. 
Initial ampliﬁ  cation with generic G-type primers yielded 
generic G genotype ampliﬁ  cation products of expected 
size (≈1,062 nt) upon gel electrophoresis. Three of the 
dipsticks yielded G3 RNA; the other 2 yielded G1 RNA. 
As proof of concept that P genotypes could be determined 
in addition to G genotypes, the P genotypes of RNA re-
covered from 2 of the 5-year-old rotavirus dipsticks 
with G3 RNA were also determined by direct sequenc-
ing of the RT-PCR products by using the generic P-type 
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Figure. Neighbor-joining phylogenetic trees 
for viral protein (VP) 7 G1, G2, G3, and G9 
genotypes of hospitalized children in Israel, 
including sequences recovered from archived 
rotavirus dipsticks (indicated by boldface). 
Representative isolates for lineages and 
sublineages of VP7 genotypes G1 (A), G2 
(B), G3 (C), and G9 (D) were chosen from 
Phan et al. (15) Page and Steele (16), 
Wang et al. (17), and Martinez-Laso et al. 
(18), respectively, and the sequences were 
downloaded from the European Molecular 
Biology Laboratory/GenBank/DNA Data 
Bank of Japan. These sequences were 
aligned with Israeli sequences by using 
the Sequencher program (Genecodes, 
Ann Arbor, MI, USA) and truncated to the 
longest segment common to all sequences 
in the alignment; 515 nt for G1, 547 nt for 
G2, 274 nt for G3, and 207 nt for G9. Each 
of the 4 phylogenetic trees was prepared by 
using ClustalX (13) for data bootstrapped 
1,000× and was analyzed with NJplot (14). 
Whole numbers indicate bootstrap values 
for branches; fractional numbers indicate 
genetic distances. The genotype, lineage, 
and, where relevant, sublineage of each 
isolate appears in brackets after the name 
of the isolate: for example, KY3303[G2.2a] 
is VP7 genotype G 2, lineage 2, sublineage 
a for isolate KY3303. A letter at the end of 
the name of the Israeli sequences indicates 
the source of the RNA (D for dipstick or S for 
fecal suspension). D&S appears when the 
sequences were identical. The GenBank 
accession numbers for all sequences in 
this  ﬁ   gure appear in the online Appendix 
Table (www.cdc.gov/EID/content/17/1/44-
appT.htm). Scale bars indicate percent of 
nucleotide substitutions per site.Rotavirus Genotypes from Rapid Test Strips
primers. Both were P[8] by sequence analysis (online Ap-
pendix Table).
The G genotypes of 3 G1s, 2 G2s, 1 G3, and 1 G9 
RNA extracted from dipsticks were conﬁ  rmed by sequenc-
ing their heminested ampliﬁ   cation products. Moreover, 
the sequences of the RNA extracted from each of the 7 
dipsticks were identical to the sequence of the RNA ex-
tracted directly from the corresponding stool suspension. 
The lineages and sublineages of these and other isolates 
from the 2005–06 season were inferred from phylogenetic 
comparisons to equivalent segments of the 11 lineages of 
G1, the 2 lineages of G2, the 4 lineages of G3, and the 
6 lineages of G9 described by Phan et al. (15), Page and 
Steele (16), Wang et al. (17), and Martinez-Laso et al. (18), 
respectively. The G3 phylogenetic tree also includes 3 se-
quences obtained from the 5-year-old dipsticks and 4 G3 
isolates from among those with highest homology to G3 
isolates from Israel identiﬁ  ed in BLAST searches (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) (19). Speciﬁ  cally,  all 
VP7 sequences for a given G genotype were aligned and 
truncated to the longest common segment. Four separate 
phylogenetic trees (Figure) were constructed because of the 
size difference between G genotype–speciﬁ  c heminested 
ampliﬁ  cation products. The lineage or sublineage of each 
isolate from Israel (online Appendix Table) was inferred 
from the relative difference of each sequence compared 
with equivalent segments of previously determined lin-
eages. For each genotype, a new lineage or sublineage was 
suggested when the sequence from Israel failed to closely 
group with the equivalent segment of >1 reference strains 
and the nucleotide differences between the strain from Is-
rael and the reference strains were similar or greater than 
the differences among reference lineages and sublineages. 
The existence of such new lineages and sublineages would 
need to be conﬁ  rmed with longer full-length open reading 
frame sequences. Finally, sequences from RNA recovered 
from dipsticks and/or from saline suspensions were used in 
BLAST searches to identify the most similar contemporary 
sequences. G1 isolates were most similar to isolates from 
Europe, the Far East, and South America; G2 isolates to 
isolates from the Far East; and G3 isolates to isolates from 
Europe and the Far East (Figure). G9 isolates were most 
similar to isolates from Africa, Europe, and the Far East.
Discussion
The G1P[8] genotype predominated in central Israel 
during the 2005–06 rotavirus season as it did throughout 
Israel during 1991–1994 (20) and in northern Israel during 
2007–2009 (2,10). However, the relative distributions of 
other genotypes differed. For example, G4P[8], absent dur-
ing 2005–2008, was present in 32.3% of samples a decade 
earlier and reappeared in 2008–09 (2). Conversely, G9 
genotypes, absent a decade earlier, were present in 15.7% 
of the 2005–06 isolates and 9.3% of the 2006–07 isolates. 
This substantial prevalence of G9 mirrors the global emer-
gence of G9 among hospitalized children in the mid-1990s 
(21,22). In addition, double infections indicated by >1 G 
or P genotype rose from <2% during 1991–1994 (20) to 
16.4% for the isolates in this study and 27% during 2007–
08 (2). As indicated by Muhsen et al (2), evidence is good 
for rotavirus reassortants emerging in vivo from appropri-
ate double infections. Phylogenetic analysis in the present 
study suggested that some G2 and G9 rotaviruses from Is-
rael belonged to new sublineages or lineages, respectively.
In conclusion, air-dried afﬁ  nity-concentrated  virus 
from rotavirus-positive bands of dipsticks yielded RNA 
suitable for G genotyping and sequencing, even for dip-
sticks stored at room temperature for 5 years. Even though 
P genotyping and sequencing was performed only on RNA 
isolated from 2 of the 5-year old dipsticks, it is reasonable 
to assume that P genotyping and sequencing would have 
been possible for the rest based on the equivalent quality of 
the RNA extracted from the dipsticks and RNA extracted 
from stool suspensions. Thus, dipsticks can be used for re-
covery of molecular epidemiologic data by reference labo-
ratories from diagnostic tests routinely performed in many 
clinical laboratories and point-of-care facilities. RNA ex-
tracted from these archived dipsticks will enable central-
ized laboratories to easily recover epidemiologically use-
ful data from the samples of other laboratories and from 
regions lacking adequate laboratory facilities. In addition, 
centralized laboratories will be able to assess whether the 
introduction of universal rotavirus vaccination changed the 
distribution of rotavirus genotypes associated with severe 
rotavirus-associated acute gastroenteritis.
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